Showing results (121-130 of 165) with videos related to
Sort By:
Pageof 17
Mathematical Biosciences and Engineering : MBE|June 14, 2024
Quantifying <i>Geobacter sulfurreducens</i> growth: A mathematical model based on acetate concentration as an oxidizing substrateVirgínia Villa-Cruz, Sumaya Jaimes-Reátegui, Juana E Alba-Cuevas, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 9, 2019
Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in SpainM A Segui, J J Cruz, E Alba, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 28, 2006
The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in SpainM Martín, E Mahillo, A Llombart-Cussac, et al.Tumori|October 31, 1992
Weekly first-line chemotherapy of metastatic breast cancer with cyclophosphamide and epirubicinE Alba, E Blanco, E Aranda, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2011
Cross-sensitivity between taxanes in patients with breast cancerA Sánchez-Muñoz, B Jiménez, A García-Tapiador, et al.American Journal of Clinical Oncology|April 1, 1996
Cisplatin, 5-fluorouracil, and high-dose folinic acid in patients with advanced unresectable head and neck cancerE Alba, M A Sanchez-Chaparro, L Alonso, et al.Antioxidants (Basel, Switzerland)|June 25, 2020
Edible Leafy Plants from Mexico as Sources of Antioxidant Compounds, and Their Nutritional, Nutraceutical and Antimicrobial Potential: A ReviewLourdes Mateos-Maces, José Luis Chávez-Servia, Araceli Minerva Vera-Guzmán, et al.Breast Cancer Research and Treatment|February 27, 2003
Sequential doxorubicin and docetaxel as first-line treatment in metastatic breast cancer: a GEICAM-9801 phase II studyE Alba, N Ribelles, A Antón, et al.Current Drug Metabolism|May 14, 2008
A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progressionN Ribelles, J López-Siles, A Sánchez, et al.International Journal of Oncology|June 14, 2011
Non-invasive monitoring of hypoxia-inducible factor activation by optical imaging during antiangiogenic treatment in a xenograft model of ovarian carcinomaB Martinez-Poveda, V Gomez, M Alcaide-German, et al.Pageof 17